Citations (98)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Kristina Lechner, Mahira Zeeshan, Maxi Noack, Hussain Ali, Markus F. Neurath & Benno Weigmann. (2022) Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD?. Expert Opinion on Drug Delivery 19:3, pages 235-245.
Read now
Read now
Sumona Saha & Arnold Wald. (2012) Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease. Expert Opinion on Drug Safety 11:6, pages 947-957.
Read now
Read now
Mohammad W Khan, Amod A Kale, Praveen Bere, Sriharsha Vajjala, Elias Gounaris & Krishna Chaitanya Pakanati. (2012) Microbes, intestinal inflammation and probiotics. Expert Review of Gastroenterology & Hepatology 6:1, pages 81-94.
Read now
Read now
Imke Atreya & Markus F Neurath. (2008) Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications. Expert Review of Gastroenterology & Hepatology 2:1, pages 23-34.
Read now
Read now
Richard J. Farrell, Subhas Banerjee & Mark A. Peppercorn. (2001) Recent Advances in Inflammatory Bowel Disease. Critical Reviews in Clinical Laboratory Sciences 38:1, pages 33-108.
Read now
Read now
P. Van Wijngaarden, M. A. C. Meijssen. (2001) Tuberculous Pleurisy: an Unusual Complication During Treatment of Crohn Disease with Azathioprine. Scandinavian Journal of Gastroenterology 36:9, pages 1004-1007.
Read now
Read now
J. Belaiche, J. P. Desager, Y. Horsmans, E. Louis. (2001) Therapeutic Drug Monitoring of Azathioprine and 6-Mercaptopurine Metabolites in Crohn Disease. Scandinavian Journal of Gastroenterology 36:1, pages 71-76.
Read now
Read now
C. B. H. W. Lamers, G. Griffioen, R. A. van Hogezand, R. A. Veenendaal. (1999) Azathioprine: an Update on Clinical Efficacy and Safety in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 34:230, pages 111-115.
Read now
Read now
Articles from other publishers (90)
Rohan V Yewale, Balakrishnan S Ramakrishna, Babu Vinish Doraisamy, Pandurangan Basumani, Jayanthi Venkataraman, Kayalvizhi Jayaraman, Ananthavadivelu Murali, Karunakaran Premkumar & Akkim Sathish Kumar. (2023) Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience. JGH Open 7:9, pages 599-609.
Crossref
Crossref
Akira Andoh, Masahiro Kawahara, Takayuki Imai, Goichi Tatsumi, Osamu Inatomi & Yoichi Kakuta. (2021) Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease. Journal of Gastroenterology 56:10, pages 881-890.
Crossref
Crossref
Rena H Cao & Michael C Grimm. (2020) Pregnancy and medications in inflammatory bowel disease. Obstetric Medicine 14:1, pages 4-11.
Crossref
Crossref
Merel M. Tielemans, Gerben A.J. van Boekel, Teun van Gelder, Eric T. Tjwa & Luuk B. Hilbrands. (2019) Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients. Transplantation Reviews 33:2, pages 55-63.
Crossref
Crossref
Jean-Frédéric Colombel. (2018) Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention. Inflammatory Bowel Diseases 24:10, pages 2173-2182.
Crossref
Crossref
Lyla Adam, Alisa Phulukdaree & Prashilla Soma. (2018) Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine. Biomedicine & Pharmacotherapy 100, pages 8-14.
Crossref
Crossref
Editorial Article. (2017) CLINICAL GUIDE OF RUSSIAN ASSOCIATION OF GASTROENTEROLOGY AND RUSSIAN ASSOCIATION OF COLOPROCTOLOGY ON DIAGNOSTICS AND TREATMENT OF CROHN'S DISEASE. Koloproktologia:2, pages 7-29.
Crossref
Crossref
J. S. Chandan & T. Thomas. (2017) Inflammatory bowel disease and oral health. BDJ Team 4:5.
Crossref
Crossref
J. S. Chandan & T. Thomas. (2017) The impact of inflammatory bowel disease on oral health. British Dental Journal 222:7, pages 549-553.
Crossref
Crossref
JUNHUA XIAO, ZHANJUN LU, JIAQING SHENG, YUNNA SONG, WEILIANG JIANG, FEI LIU & PING ZHENG. (2016) 5-Fluorouracil attenuates dextran sodium sulfate-induced acute colitis in mice. Molecular Medicine Reports 13:3, pages 2821-2828.
Crossref
Crossref
Gerda C Leitner. (2016) Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 5.
Crossref
Crossref
Miranda Muhvić-Urek, Marija Tomac-Stojmenović & Brankica Mijandrušić-Sinčić. (2016) Oral pathology in inflammatory bowel disease. World Journal of Gastroenterology 22:25, pages 5655.
Crossref
Crossref
Stephen B. Hanauer & Daniel K. Podolsky. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1378
1417
.
E. G. Quetglas, A. Armuzzi, S. Wigge, G. Fiorino, L. Barnscheid, M. Froelich & Silvio Danese. (2015) Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. European Journal of Clinical Pharmacology 71:7, pages 773-799.
Crossref
Crossref
Jaimin Amin, Brian Huang, Jessica Yoon & David Q. Shih. (2015) Update 2014. Inflammatory Bowel Diseases 21:2, pages 445-452.
Crossref
Crossref
K. Kato, T. Ohkusa, S. Terao, T. Chiba, K. Murakami, A. Yanaka, T. Uehara, Y. Ishii, M. Soma & H. Tajiri. (2014) Adjunct antibiotic combination therapy for steroid‐refractory or ‐dependent ulcerative colitis: an open‐label multicentre study. Alimentary Pharmacology & Therapeutics 39:9, pages 949-956.
Crossref
Crossref
HUA-RONG HUANG, HUI ZAN, YING LIN & YING-QIANG ZHONG. (2014) Effects of azathioprine and infliximab on mesenchymal stem cells derived from the bone marrow of rats in vitro. Molecular Medicine Reports 9:3, pages 1005-1012.
Crossref
Crossref
Andrea C. Bafford, Sarah Powers, Christina Ha, Danielle Kruse, Stephen R. Gorfine, David B. Chessin & Joel J. Bauer. (2013) Immunosuppressive Therapy Does Not Increase Operative Morbidity in Patients With Crohn’s Disease. Journal of Clinical Gastroenterology 47:6, pages 491-495.
Crossref
Crossref
Xiang Gao, Fang-bin Zhang, Liang Ding, Hui Liu, Xue-ding Wang, Bai-li Chen, Hui-chang Bi, Ying-Lian Xiao, Li-zi Zhao, Min-hu Chen, Min Huang & Pin-jin Hu. (2012) The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology 24:8, pages 958-964.
Crossref
Crossref
Liang Ding, Fang-bin Zhang, Hui Liu, Xiang Gao, Hui-chang Bi, Xue-ding Wang, Bai-li Chen, Yu Zhang, Li-zi Zhao, Guo-ping Zhong, Pin-jin Hu, Min-hu Chen & Ming Huang. (2012) Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 18:1, pages 63-73.
Crossref
Crossref
Emma Calabrese & Stephen B. Hanauer. (2011) Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease. Journal of Crohn's and Colitis 5:1, pages 48-53.
Crossref
Crossref
Joseph Prandota. (2010) Advances of Molecular Clinical Pharmacology in Gastroenterology and Hepatology. American Journal of Therapeutics 17:5, pages e137-e162.
Crossref
Crossref
Gerhard Rogler. (2010) Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Practice & Research Clinical Gastroenterology 24:2, pages 157-165.
Crossref
Crossref
Miles P. Sparrow, Peter M. Irving & Stephen B. Hanauer. (2009) Optimizing conventional therapies for inflammatory bowel disease. Current Gastroenterology Reports 11:6, pages 496-503.
Crossref
Crossref
Geert R. D'Haens, Severine Vermeire, Gert Van Assche, Maja Noman, Isolde Aerden, Gust Van Olmen & Paul Rutgeerts. (2008) Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial. Gastroenterology 135:4, pages 1123-1129.
Crossref
Crossref
Javier P. Gisbert & Fernando Gomolln. (2008) Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review. The American Journal of Gastroenterology 103:7, pages 1783-1800.
Crossref
Crossref
Ferenc Nagy, Tamás Molnár, Zoltán Szepes, Klaudia Farkas, Tibor Nyári & János Lonovics. (2008) Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease. World Journal of Gastroenterology 14:27, pages 4342.
Crossref
Crossref
I. Atreya & M. F. Neurath. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice
153
161
.
Tilo Stolzenburg, Ken Ljungmann & Henrik Christensen. (2007) The Effect of Azathioprine on Anastomotic Healing: An Experimental Study in Rats. Diseases of the Colon & Rectum 50:12, pages 2203-2208.
Crossref
Crossref
Jörg Emmrich, Sebastian Petermann, Dietrich Nowak, Ingolf Beutner, Peter Brock, Reinhard Klingel, Patrick Mausfeld-Lafdhiya, Stefan Liebe & Wolfgang Ramlow. (2007) Leukocytapheresis (LCAP) in the Management of Chronic Active Ulcerative Colitis—Results of a Randomized Pilot Trial. Digestive Diseases and Sciences 52:9, pages 2044-2053.
Crossref
Crossref
Ashwin N. Ananthakrishnan, Tan Attila, Mary F. Otterson, Randolph J. Lipchik, Benson T. Massey, Richard A. Komorowski & David G. Binion. (2007) Severe Pulmonary Toxicity After Azathioprine/6-Mercaptopurine Initiation for the Treatment of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 41:7, pages 682-688.
Crossref
Crossref
Brahma N. Singh & Kwon H. Kim. (2007) Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery. International Journal of Pharmaceutics 341:1-2, pages 143-151.
Crossref
Crossref
Todd Ponsky, Anna Hindle & Anthony Sandler. (2007) Inflammatory Bowel Disease in the Pediatric Patient. Surgical Clinics of North America 87:3, pages 643-658.
Crossref
Crossref
Juan L. Mendoza, Elena Urcelay, Raquel Lana, Carmen M. Martín, Natalia López, Luis G. Guijarro, Julio A Mayol, Carlos Taxonera, Emilio G. de la Concha, Amado S. Peña & Manuel Díaz-Rubio. (2007) MDR1 polymorphisms and response to azathioprine therapy in patients with Crohnʼs disease. Inflammatory Bowel Diseases 13:5, pages 585-590.
Crossref
Crossref
Miles P. Sparrow, Scott A. Hande, Sonia Friedman, Dingcai Cao & Stephen B. Hanauer. (2007) Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Nonresponders to Azathioprine or 6-Mercaptopurine. Clinical Gastroenterology and Hepatology 5:2, pages 209-214.
Crossref
Crossref
L. J. J. DERIJKS, L. P. L. GILISSEN, P. M. HOOYMANS & D. W. HOMMES. (2006) Review article: thiopurines in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 24:5, pages 715-729.
Crossref
Crossref
Caroline J. Green & Anthony S. Mee. (2006) Re-introduction of azathioprine in previously intolerant patients. European Journal of Gastroenterology & Hepatology 18:1, pages 17-19.
Crossref
Crossref
Gwo-Tzer Ho, Alexandra J. Seddon, George Therapondos, Jack Satsangi & Peter C. Hayes. (2005) The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation. European Journal of Gastroenterology & Hepatology 17:12, pages 1379-1385.
Crossref
Crossref
M. P. SPARROW, S. A. HANDE, S. FRIEDMAN, W. C. LIM, S. I. REDDY, D. CAO & S. B. HANAUER. (2005) Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Alimentary Pharmacology & Therapeutics 22:5, pages 441-446.
Crossref
Crossref
Lori Kam & Eric A. Vasiliauskas. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
409
429
.
Pilar Nos, Vicente Garrigues, Guillermo Bastida, Nuria Maroto, Marta Ponce & Julio Ponce. (2004) Outcome of Patients with Nonstenotic, Nonfistulizing Crohn’s Disease. Digestive Diseases and Sciences 49:11-12, pages 1771-1776.
Crossref
Crossref
Laurent Beaugerie, Antoine Blain, Franck Brazier, Jean-Marc Gornet & Yann Parc. (2004) Traitement de la rectocolite ulcéro-hémorragique dans sa forme étendue (colite grave exclue). Gastroentérologie Clinique et Biologique 28:10, pages 974-983.
Crossref
Crossref
W. Seidel. (2004) Panzytopenie unter kombinierter Behandlung mit Azathioprin und AllopurinolPanzytopenia from combination therapy with azathioprin and allopurinol. Zeitschrift f�r Rheumatologie 63:5, pages 425-427.
Crossref
Crossref
Stephen B. Hanauer, Burton I. Korelitz, Paul Rutgeerts, Mark A. Peppercorn, Ronald A. Thisted, Russell D. Cohen & Daniel H. Present. (2004) Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial. Gastroenterology 127:3, pages 723-729.
Crossref
Crossref
M. Vilien, J. F. Dahlerup, L. K. Munck, P. Nørregaard, K. Grønbæk & J. Fallingborg. (2004) Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year. Alimentary Pharmacology & Therapeutics 19:11, pages 1147-1152.
Crossref
Crossref
H??ctor Corominas & Montserrat Baiget. (2004) Clinical Utility of Thiopurine S-Methyltransferase Genotyping. American Journal of PharmacoGenomics 4:1, pages 1-8.
Crossref
Crossref
Eric Vasiliauskas. (2003) Recent advances in the diagnosis and classification of inflammatory bowel disease. Current Gastroenterology Reports 5:6, pages 493-500.
Crossref
Crossref
Loren Laine & Stephen B Hanauer. (2003) Considerations in the management of steroid-dependent Crohn’s disease. Gastroenterology 125:3, pages 906-910.
Crossref
Crossref
B. Bonaz, J. Boitard, P. Marteau, M. LÉmann, B. Coffin, B. Flourié, J. Belaiche, G. Cadiot, E.‐H. Metman, A. Cortot & J.‐F. Colombel. (2003) Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Alimentary Pharmacology & Therapeutics 18:4, pages 401-408.
Crossref
Crossref
S Campbell & S Ghosh. (2003) Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome. Digestive and Liver Disease 35:8, pages 546-551.
Crossref
Crossref
Raymond C Givens & Paul B Watkins. (2003) Pharmacogenetics and clinical gastroenterology. Gastroenterology 125:1, pages 240-248.
Crossref
Crossref
Thomas R Ziegler, Concepción Fernández-Estívariz, Li H Gu, Michael W Fried & Lorraine M Leader. (2003) Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology 124:7, pages 1950-1957.
Crossref
Crossref
Marla C. Dubinsky, Edward J. Feldman, Maria T. Abreu, Stephan R. Targan & Eric A. Vasiliauskas. (2003) Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. The American Journal of Gastroenterology 98:5, pages 1058-1063.
Crossref
Crossref
Stephen B. Hanauer. (2003) Crohn's disease: step up or top down therapy. Best Practice & Research Clinical Gastroenterology 17:1, pages 131-137.
Crossref
Crossref
Luc JJ Derijks, Dirk J de Jong, Lennard PL Gilissen, Leopold GJB Engels, Piet M Hooymans, Jan BMJ Jansen & Chris JJ Mulder. (2003) 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology 15:1, pages 63-67.
Crossref
Crossref
L. O. Reuther, J. Sonne, N. Larsen, J. F. Dahlerup, O. O. Thomsen & K. Schmiegelow. (2002) Thiopurine methyltransferase genotype distribution in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics 17:1, pages 65-68.
Crossref
Crossref
M. Reinshagen. 2003. Chronisch entzündliche Darmerkrankungen. Chronisch entzündliche Darmerkrankungen
103
110
.
Lori Kam & Eric A. Vasiliauskas. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
409
429
.
Ingrid LangezaalSebastian Hoffmann, Thomas HartungSandra Coecke. (2019) Evaluation and Prevalidation of an Immunotoxicity Test Based on Human Whole-blood Cytokine Release. Alternatives to Laboratory Animals 30:6, pages 581-595.
Crossref
Crossref
Uma Mahadevan, Edward V. LoftusJr.Jr., William J. Tremaine, John H. Pemberton, W. Scott Harmsen, Cathy D. Schleck, Alan R. Zinsmeister & William J. Sandborn. (2002) Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications. Inflammatory Bowel Diseases 8:5, pages 311-316.
Crossref
Crossref
Miguel Regueiro & Houssam Mardini. (2002) Determination of Thiopurine Methyltransferase Genotype or Phenotype Optimizes Initial Dosing of Azathioprine for the Treatment of Crohn’s Disease. Journal of Clinical Gastroenterology 35:3, pages 240-244.
Crossref
Crossref
Pilar Nos, Joaquín Hinojosa, Julio Mora, Vicente Garrigues & Julio Ponce. (2002) Validation of a simplified clinical index to predict evolving patterns in Crohn's disease. European Journal of Gastroenterology & Hepatology 14:8, pages 847-851.
Crossref
Crossref
Matthias Schwab, Elke Schaffeler, Claudia Marx, Christine Fischer, Thomas Lang, Christoph Behrens, Michael Gregor, Michel Eichelbaum, Ulrich Zanger & Bernd Kaskas. (2002) Pharmacogenetics 12:6, pages 429-436.
Crossref
Crossref
Birgitta Pettersson, Sven Almer, Freidoun Albertioni, Stefan Söderhäll & Curt Peterson. (2002) Differences Between Children and Adults in Thiopurine Methyltransferase Activity and Metabolite Formation During Thiopurine Therapy: Possible Role of Concomitant Methotrexate. Therapeutic Drug Monitoring 24:3, pages 351-358.
Crossref
Crossref
A. Barabino, F. Torrente, A. Ventura, S. Cucchiara, M. Castro & C. Barbera. (2002) Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey. Alimentary Pharmacology & Therapeutics 16:6, pages 1125-1130.
Crossref
Crossref
Janine E. Polifka & J.M. Friedman. (2002) Teratogen update: Azathioprine and 6‐mercaptopurine. Teratology 65:5, pages 240-261.
Crossref
Crossref
R. N. Cunliffe & B. B. Scott. (2002) Monitoring for drug side‐effects in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 16:4, pages 647-662.
Crossref
Crossref
Daniel A. Lombardi, Edward R. Feller & Samir A. Shah. (2002) Medical management of inflammatory bowel disease in the new millennium. Comprehensive Therapy 28:1, pages 39-49.
Crossref
Crossref
J.P. Gisbert, J. Maté, J.M. Pajares & F. Gomollón. (2002) Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 25:6, pages 401-415.
Crossref
Crossref
O. H. Nielsen, B. Vainer & J. Rask‐Madsen. (2008) The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprine. Alimentary Pharmacology & Therapeutics 15:11, pages 1699-1708.
Crossref
Crossref
James D. Lewis, Warren B. Bilker, Colleen Brensinger, Julius J. Deren, David J. Vaughn & Brian L. Strom. (2001) Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:5, pages 1080-1087.
Crossref
Crossref
Puneet Gupta, Ranjana Gokhale & Barbara S. Kirschner. (2001) 6-Mercaptopurine Metabolite Levels in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 33:4, pages 450-454.
Crossref
Crossref
Puneet GuptaRanjana GokhaleBarbara S. Kirschner. (2001) 6‐Mercaptopurine Metabolite Levels in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 33:4, pages 450-454.
Crossref
Crossref
Kimberly M. Persley & Daniel H. Present. (2001) Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 13:9, pages 1053-1055.
Crossref
Crossref
M. Corbett & M. Schlup. (2001) Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Internal Medicine Journal 31:6, pages 366-367.
Crossref
Crossref
Matthias Schwab, Elke Schaeffeler, Claudia Marx, Ulrich Zanger, Walter Aulitzky & Michel Eichelbaum. (2001) Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only. Gastroenterology 121:2, pages 500-501.
Crossref
Crossref
L Girodengo, M Barthet, A Desjeux, S Berdah, P Berthezene, P Bellon, J Salducci & J.C Grimaud. (2001) Facteurs de récidive de la maladie de Crohn après traitementdes sténoses intestinales. Annales de Chirurgie 126:4, pages 296-301.
Crossref
Crossref
Stephen B. Hanauer & William Sandborn. (2001) Management of Crohn's disease in adults. The American Journal of Gastroenterology 96:3, pages 635-643.
Crossref
Crossref
Wolfgang Miehsler, Walter Reinisch, Gabriele Moser, Alfred Gangl & Harald Vogelsang. (2001) Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?. The American Journal of Gastroenterology 96:3, pages 782-787.
Crossref
Crossref
Fergus Shanahan. (2001) Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:3, pages 622-635.
Crossref
Crossref
P.Martínez Tirado, E.Redondo Cerezo, Y.Gónzalez Aranda, M.J. Cabello Tapia, F.Nogueras López & M.R.Gómez García. (2001) Linfoma ki-1 cutáneo en paciente con enfermedad de crohn en tratamiento con azatioprina. Gastroenterología y Hepatología 24:5, pages 271-272.
Crossref
Crossref
Miguel D. Regueiro. (2000) Update in Medical Treatment of Crohn's Disease. Journal of Clinical Gastroenterology 31:4, pages 282-291.
Crossref
Crossref
F. Castiglione, G. Del Vecchio Blanco, A. Rispo, A. Cozzolino, E. Di Girolamo, D. Cappuccio & G. Mazzacca. (2000) Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Digestive and Liver Disease 32:7, pages 626-629.
Crossref
Crossref
Eric Vasiliauskas. (2000) Pediatric inflammatory bowel disease. Current Treatment Options in Gastroenterology 3:5, pages 403-424.
Crossref
Crossref
Fabiana Castiglione, Giovanna Vecchio Blanco, Antonio Rispo & Gabriele Mazzacca. (2000) Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine. The American Journal of Gastroenterology 95:9, pages 2394-2395.
Crossref
Crossref
F. Hoffmeyer, M. M. Hoeper, E. Spiekerk??tter, W. Harringer, A. Haverich, H. Fabel & J. Niedermeyer. (2000) AZATHIOPRINE WITHDRAWAL IN STABLE LUNG AND HEART/LUNG RECIPIENTS RECEIVING CYCLOSPORINE-BASED IMMUNOSUPPRESSION. Transplantation 70:3, pages 522-525.
Crossref
Crossref
Muthoka Mutinga, Mariana Castells, Richard Horan & Francis A Farraye. (2000) Successful Desensitization To 6-Mercaptopurine in A Patient With Crohn's Disease. American Journal of Gastroenterology 95:5, pages 1383-1384.
Crossref
Crossref
Bell & Kamm. (2001) Review article: the clinical role of anti‐TNFα antibody treatment in Crohn's disease. Alimentary Pharmacology & Therapeutics 14:5, pages 501-514.
Crossref
Crossref
Annette Rowlinson. (1999) Inflammatory bowel disease 2: medical and surgical treatment. British Journal of Nursing 8:14, pages 926-930.
Crossref
Crossref
Stephen B. Hanauer. (1999) Medical therapy for Crohn’s disease. Current Opinion in Gastroenterology 15:4, pages 308.
Crossref
Crossref